Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,733,657 papers from all fields of science
Search
Sign In
Create Free Account
Alprenolol
Known as:
Aprenololo
, Alprenololum
, (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol
Expand
One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
26 relations
Narrower (11)
4-hydroxyalprenolol
4-hydroxyalprenolol glucuronide
Alpheprol
Aptin
Expand
Broader (5)
Adrenergic beta-Antagonists
Amino Alcohols
Anti-Arrhythmia Agents
Antihypertensive Agents
Expand
Alprenolol Hydrochloride
Alprenolol:MCnc:Pt:Ser/Plas:Qn
Alprenolol:Mass:Pt:Dose:Qn
In Blood
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
Jan Pape
Acta medica Scandinavica. Supplementum
2009
Corpus ID: 44766389
Seventeen patients with moderate essential hypertension were included in a double-blind crossover study, comparing the…
Expand
2009
2009
Metabolic interaction of ethanol and alprenolol in isolated liver cells.
R. Grundin
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 31671338
: Metabolism of ethanol and alprenolol was studied in isolated rat liver cells. At low ethanol concentrations, where the rate of…
Expand
2009
2009
Long-term effect of alprenolol as antihypertensive agent.
Calle Bengtsson
Acta medica Scandinavica. Supplementum
2009
Corpus ID: 2312902
Abstract Alprenolol was given to 26 women, participants in a population study, who were found to have arterial hypertension…
Expand
2009
2009
A long-term study of the antihypertensive effect of alprenolol.
M. Comerford
,
A. Pringle
Acta medica Scandinavica. Supplementum
2009
Corpus ID: 36569780
Twenty patients, known to have essential hypertension, were treated for an average period of 30 months with alprenolol (Aptin…
Expand
2009
2009
Complaints of cold extremities among patients on antihypertensive treatment.
E. Feleke
,
O. Lyngstam
,
L. Råstam
,
Lars Rydén
Acta Medica Scandinavica
2009
Corpus ID: 1902628
A total of 758 consecutive patients attending three hypertension clinics answered a questionnaire designed to assess the…
Expand
2009
2009
Effects of alprenolol and isosorbide dinitrate in angina pectoris. A comparative study with methodological considerations.
O. Keyriläinen
,
G. Nyberg
,
A. Uusitalo
Acta Medica Scandinavica
2009
Corpus ID: 6075991
Seventeen patients suffering from exertional angina pectoris according to their records, and confirmed by exercise testing, have…
Expand
1980
1980
Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction.
Stanley G. Rockson
,
C. Homcy
,
E. Haber
Circulation Research
1980
Corpus ID: 12157027
We immunized rabbits with an antigen prepared by covalent linkage of alprenolol, a beta-adrenergic receptor antagonist, to bovine…
Expand
1979
1979
Improved electron-capture GLC determination of alprenolol and oxprenolol in serum using a wall-coated open tubular column.
D. Debruyne
,
H. Kinsun
,
M. Moulin
,
M. Bigot
Journal of Pharmacy and Science
1979
Corpus ID: 8723956
An accurate, rapid, and sensitive GLC determination of alprenolol and oxprenolol in serum is described. This method combines an…
Expand
1979
1979
Characterization and solubilization of the alpha-adrenoreceptor of rat liver plasma membranes labeled with [3H]phenoxybenzamine.
G. Guellaen
,
M. Aggerbeck
,
Jacques Hanoune
Journal of Biological Chemistry
1979
Corpus ID: 26503376
The aim of the present study was to demonstrate that [‘Hlphenoxybenzamine ([3H]POB) labeled at a sufflciently high specific…
Expand
Review
1978
Review
1978
Individual Differences in the Disposition of Drugs Metabolised in the Body
G. Alvan
Clinical Pharmacokinetics
1978
Corpus ID: 40818529
Drug disposition in the body is subject to marked interindividual variability. On multiple dosing, steady state plasma…
Expand